News Hub | News Direct

All Industries


Article thumbnail News Release

ABOUND Energy & Zinc8 Energy Solutions USA Unveil Q1 Highlights and Renew Commitment to Establishing Commercial Manufacturing Facility and US Headquarters in Ulster County, New York

Abound Energy Inc.

VANCOUVER, BC – TheNewswire - April 3, 2024 - ABOUND Energy Inc. (“ ABOUND ” or the “ Company ”) (CSE:ABND) (OTC:ZAIRF) (FSE:0E9) and its wholly-owned subsidiary, ZINC8 Energy Solutions USA, Inc. (“ ZINC8 USA ”) are pleased to jointly announce that we have reaffirmed the commitment between our companies and Empire State Development, initially established in January 2023, Zinc8 USA’s intention to establish our US headquarters and an eco-friendly Commercial Manufacturing Facility for clean, sustainable energy technologies in Ulster County, New York.   Zinc8 USA is collaborating with various stakeholders on the project, including local authorities, the iPark87 Business Park, and other partners, to set a revised target start date for 2025. This revised timeline more accurately aligns with the updated schedule announced by Zinc8 USA's parent company, ABOUND ENERGY. National Resources, the proprietor of iPark87, has been actively investing in the site's remediation, refurbishment, and enhancements to its infrastructure and facilities. It foresees that Zinc8 USA's prospective location will be prepared for occupancy by the conclusion of 2024.   The expansion in New York aligns with Governor Hochul's framework for the state to install six gigawatts of energy storage by 2030. Zinc8 USA is poised to expedite the global transition to sustainable, secure, and resilient energy sources. Through environmentally and economically friendly mass storage systems, Zinc8 USA aims to make clean energy storage cost-effective, reliable, and readily available, thus contributing significantly to achieving the state's ambitious energy storage goals.   Robert Parker, CEO of Zinc8 USA, stated, “Despite the recent challenges encountered by various clean technology projects in the region, setbacks in iPark87’s timetable for Zinc8 USA’s potential new home, and the turbulence and issues faced by ABOUND since last Fall, it has remained evident that Zinc8 USA's most promising opportunities for success and growth lie in New York. Throughout this challenging period, our conviction in this assessment has never wavered. Over the past six months, I have actively collaborated with numerous stakeholders involved in the project to ensure its continuous progress. While there are still several matters to address, not all of which are within our control, reaching this milestone is undoubtedly a positive step worth celebrating as we aspire to become an integral part of the Ulster County community for years to come. Much of the credit for the resiliency demonstrated by Abound and Zinc8 USA is owed to the efforts of the new leadership team, whose contributions have been indispensable to our short-term survival and positioning us for long-term success.”   “Abound is proud to uphold our commitment to bringing world-class, environmentally friendly manufacturing to New York State, a global leader in the fight against Climate Change. The Zinc8 USA team boasts an extensive track record of successfully launching the manufacture of new technologies and has demonstrated exceptional prowess in navigating the complexities of global markets to establish successful collaborations with industry leaders. We firmly believe that Mr. Parker’s leadership, his dedication to Abound, the Zaeras™ LDES technology, and deploying innovative Cleantech solutions, along with his commitment to this project and the community, will ensure that the time and resources invested in this endeavor are a success for Abound and all stakeholders crucial to our achievements in Ulster County," stated Jason Birmingham, President and CEO of ABOUND Energy.    Corporate Highlights Q1 2024   Rebranded as ABOUND Energy, we launched our expanded corporate initiative, which includes a new corporate revenue strategy. This initiative offers comprehensive solutions that integrate ABOUND’s core competencies and infrastructure. By incorporating various clean technologies, we have developed an innovative, integrated energy solution tailored for the market.   The induction of a dynamic new board of directors, heralding a fresh era of leadership: Mr. Keith Morlock, Mr. Scott Larson, and Mr. Mike Simpson   The appointment of Keith Morlock as the COO of ABOUND, joining the executive team of Jason Birmingham, CEO and Swapan Kakaumanu, CFO.   Formation of the Advisory Board to assist with the strategic vision: Mrs. Talia Becket-Davis, Mr. Lee Harrison, and Mr. Robert Schwetzke.   The affirmation of Zinc8 USA's value proposition and commitment to the US market is underscored by the appointment of Mr. Doug MacDonlad as CSO and Robert Parker as CEO.   Signed a service agreement with AZUL Energy, a leading catalyst producer, marking our first revenue milestone. The project officially commenced on April 1st, with activities already underway at our facility.   An MOU has been executed with a technology company that offers the market an innovative, environmentally friendly, green energy solution.   The Announcement of private placement to raise gross proceeds of up to CA$1,500,000      “Recent adjustments in leadership, governance, and operational structure within Abound were strategically implemented to facilitate the efficient market entry of our Zaeras™ Long-Duration Energy Storage technology. These management changes along with both the commencement of the collaboration with AZUL and the announcement of an extension to a new target date will enable ABOUND to diversify its revenue streams through strategic partnerships and corporate structure. These critical adjustments are indispensable for establishing the future production capacity and operational excellence necessary to scale ABOUND's manufacturing capacity in the coming years.” stated Keith Morlock, COO of ABOUND Energy    About ABOUND Energy Inc. ABOUND specializes in developing scalable, environmentally friendly, long-lasting energy technology. Our patented Zaeras™ long-duration energy storage technology, leveraging zinc-air chemistry, guarantees the storage and on-demand delivery of electricity without the limitations or environmental risks associated with current market leaders.   About ABOUND’s Zaeras™ Technology Zaeras™ is precision-engineered to meet future energy requirements, with a specific emphasis on simplifying long-duration energy storage. Harnessing the potential of its multi-patented Zaeras™ technology, ABOUND is poised to facilitate the seamless integration of green energy sources into the grid. This is achieved by minimizing curtailment, bridging the gap between supply and demand, and efficiently integrating green energy into the grid. ABOUND's strategic initiatives encompass opportunities for peak demand reduction, leveraging time-of-use arbitrage, participating in value stacking programs, and entering the distributed long-duration energy storage sector. These endeavors are aligned with our central objective of increasing the integration and resiliency of green energy, while stabilizing the grid. Distinguished by its inherent safety—free from fire or explosion hazards—Zaeras™ guarantees sustained capacity over an extensive lifecycle. Simultaneously, it showcases versatility by independently managing charge and discharge operations. Comparable to other Flow Battery technologies, scaling up the energy capacity of Zaeras™ is as simple as increasing the size of the fuel tank; a cost-effective solution, from kWh to MWh.  This is a welcome alternative to the fixed power-to-energy ratio constraints ingrained in traditional systems, such as Li-ion and Zinc Hybrid Batteries. To learn more about ABOUND’s technology, please visit: https://Abound.Energy   About Empire State Development The mission of Empire State Development (“ESD”) is to promote a vigorous and growing state economy, encourage business investment and job creation, and support diverse, prosperous local economies across New York State through the efficient use of loans, grants, tax credits, real estate development, marketing and other forms of assistance. To learn more about Empire State Development and New York’s support for economic growth in the state, please visit: https://esd.ny.gov/    For more information please contact: ABOUND Energy Inc. Email: Investors@Abound.Energy Ph: +1 (672) 887-9688   Notice Regarding Forward Looking Statements This news release may contain certain “forward looking statements.” Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Any forward-looking statement speaks only as of the date of this news release and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result o f new information, future events, or results or otherwise.

April 03, 2024 12:25 PM Eastern Daylight Time

Article thumbnail News Release

“Learning” Reimagined with Dr. Trimpe Leading the Charge for Employee Development

Prodigy Press Wire

In today’s fast-paced and ever-evolving business landscape, the traditional approach to employee development is facing increasing scrutiny. As organizations grapple with the challenges of navigating uncertainty, driving innovation, and fostering resilience, the need for a paradigm shift in training has never been more apparent. The predominant model of training often relies on standardized curricula, lecture-based formats, and passive instructional methods. While these approaches may have served their purpose in the past, they fall short in meeting the dynamic and complex demands of today's business roles. As Dr. Debora Trimpe, President of Prime Performance Strategies, astutely observes, “Traditionally, training means putting people in a classroom and lecturing to them. But it may not be the most effective way, especially for adults to learn. We don’t train human beings. We develop them. We generally train dogs.” Instead of focusing on specific concepts or activities, she encourages group discussions and problem-solving, allowing individuals to work together to develop solutions to real-world problems. This approach helps develop a person’s skills and contributes to their success. Dr. Trimpe also advocates role-playing in adult learning to help people develop new skills and apply them in real-life situations. Technology also plays a crucial role in modern employee development efforts. Virtual platforms, interactive modules, and multimedia resources enable participants to engage with content in a manner that is flexible, accessible, and engaging. Dr. Trimpe’s use of technology as an enabler of learning reflects a forward-thinking approach to employee development in the digital age. A renewed focus on individual growth and empowerment is at the heart of this shift. It should not be seen as a one-time event but as an ongoing journey of continuous learning. Dr. Trimpe’s philosophy of fostering a culture of growth resonates deeply in this regard. By prioritizing the holistic development of individuals, organizations can cultivate a cadre of leaders and employees equipped not only with the requisite skills and knowledge but also with the resilience, adaptability, and vision necessary to thrive in an ever-changing world. However, this transformation has its own challenges. Skepticism within the human resources community, resistance to change, and a lack of understanding of adult learning principles pose significant obstacles to progress. Industrial and organizational (I/O) psychologists focus on the behavior of employees in the workplace. Yet, we rarely see these specialists working in the corporate world, even though they are the ones who have the skills and knowledge to improve employee performance and satisfaction. Dr. Debora Trimpe, herself has a Ph.D. in Industrial and Organizational Psychology. With 40+ years of experience in adult learning, talent development, and coaching, she has helped many professionals, across various industries, increase their profitability and she applies psychological theory and principles to obtain success. After spending hours working alongside individuals, she has developed these programs outside the sterile confines of an office. She creates learning and development strategies from experiences, keeping the client’s work environment in mind. Dr. Debora Trimpe believes that the time has come for a fundamental shift in how we approach employee development. By moving beyond traditional training methodologies, embracing personalized development strategies, leveraging technology as an enabler of learning, and prioritizing individual growth and empowerment, we can create a new era of excellence. The future of employee performance lies in our ability to adapt, innovate, and evolve in response to the changing needs of the modern world. As a testament to her transformative approach, numerous professionals have attested to the profound impact of Dr. Trimpe’s mentorship. “After 20 years in my industry and having reached the top percentile within it, I thought I knew almost everything,” reflects one client. “But after the first session with Debora, I was extremely impressed, and since then I have learned a lot in working with her over the years.” With a renewed focus on individual development, organizations can cultivate a cadre of professionals equipped not only with the requisite skills and knowledge but also with the resilience, adaptability, and vision necessary to thrive in an ever-changing world. Media Contact Name: Dr. Debora Trimpe Email: debora@primeperformancestrategies.com Release ID: 984898

April 03, 2024 11:30 AM Eastern Daylight Time

Article thumbnail News Release

MedCognetics Secures Groundbreaking Patent for Inclusive, Unbiased Medical Imaging AI Technology in Mammography

MedCognetics

In a significant stride towards equitable healthcare technology, MedCognetics, Inc., a company focusing on medical imaging AI, today announced it has been awarded patent number 11,948,297 by the United States Patent and Trademark Office (USPTO). The patent covers architectural strategies and methodologies for achieving unbiased AI in breast imaging. This innovation is backed by MedCognetics’ peer-reviewed publications in industry conferences such as the Radiological Society North America (RSNA) 2023, the European Society of Radiology (ESR) 2024, and a grant from the National Institutes of Health (NIH). This breakthrough is set to redefine the development of AI in the medical field ensuring MedCognetics’ algorithms maintain high performance across different patient demographics, thereby guaranteeing consistent, fair, superior patient outcomes. "This patent is a reflection of our team's focused pursuit of innovation and commitment to inclusivity,” said Ron Nag, CEO of MedCognetics, Inc. “Our technology is not just about improving patient outcomes through earlier and more accurate diagnoses; the focus is on fostering equality in technological development and ensuring universal access to advancements in healthcare systems worldwide. We remain dedicated to progressing in the field of unbiased medical imaging technology.” MedCognetics is actively engaged in partnerships with leading healthcare institutions and research organizations to bring its patented AI technology into clinical practice, aiming for widespread patient benefit from these advancements at the earliest. Full details of the allowance are listed in the Issue Notification Certificate issued by the USPTO. For further information about MedCognetics and its pioneering medical imaging AI technology, please visit www.medcognetics.com. About MedCognetics, Inc. MedCognetics provides an advanced AI software platform that integrates into radiology workflow. In addition, the AI algorithm is trained on a diverse global patient dataset to mitigate data biasing. The future of AI in healthcare is unbiased services and MedCognetics is at the forefront of creating a more predictable medical outcome and ultimately saving lives. Founded in 2020, the company is based in Dallas, Texas. For more information, please visit our website at www.medcognetics.com. Contact Details ANW Networks Alicia Nieva-Woodgate +1 415-515-0866 alicia@anwnetworks.com Company Website https://www.medcognetics.com

April 03, 2024 11:30 AM Eastern Daylight Time

Article thumbnail News Release

Nextech3D.ai protects intellectual property with a patent for generating 3D models from 2D images

Nextech3D.AI

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce a significant milestone for the company as the U.S. Patent and Trademark Office (USPTO) officially issued a patent for their technology to generate three-dimensional models from two-dimensional images. Gappelberg emphasized the importance of this patent in the realm of artificial intelligence (AI) and 2D to 3D model generation, describing it as a pivotal patent for the 3D modeling industry. He highlighted that this patent adds substantial value to Nextech3D.ai and positions the company as one of the technology leaders in the field of converting 2D photos to 3D models using AI. The issuance of this patent provides Nextech3D.ai with a competitive advantage, setting them apart from other companies involved in 3D model generation. Gappelberg expressed confidence that this patent, along with a second AI patent issuance and seven additional patents filed, strengthens the company's position and builds a moat around their 3D model-making business for e-commerce. With a focus on both industry expertise and intellectual property, including GPT AI-powered 3D model generation, Nextech3D.ai aims to increase shareholder value by investing in 3D-AI GPT patents and solutions. Gappelberg emphasized that this second AI patent approval reinforces and validates the company's commitment to innovation and generating substantial revenue through 3D modeling. Contact Details Proactive United States +1 347-449-0879 action@proactiveinvestors.com

April 03, 2024 11:20 AM Eastern Daylight Time

Video
Article thumbnail News Release

First Phosphate 2nd set of assays at Begin-Lamarche shows 2 metre vein of massive Apatite

First Phosphate Corp

First Phosphate Corp CEO John Passalacqua and Chief Geologist Gilles Laverdiere joined Steve Darling from Proactive to provide an update on the company's 25,000-meter drill program at the Bégin-Lamarche project in Quebec. So far, the company has drilled 16,435 meters, with assays back from 5,642 meters. Passalacqua explained to Proactive that drilling at the Phosphate Mountain Zone continues to deliver strong phosphate mineralization. Both the Mountain and Northern Zones exhibit high-grade phosphate on the surface, while the Southern Zone shows large tonnage potential over a strike length of 1.5 kilometers. At the Phosphate Mountain Zone: Drill hole BL-24-48 intersected 15.01% P2O5 (phosphate) over 7.65 meters from a depth of 36.9 meters, including one assay of 31.24% P2O5 over 1.1 meters. Other drill holes in this zone also yielded core results of 30%+ apatite. The Northern Zone included drill hole BL-24-36 intersected 6.83% P2O5 over 108.0 meters starting at a depth of 234.0 meters. Drill hole BL-24-44 intersected 7.48% P2O5 over 90.6 meters starting at a depth of 192.4 meters. At the Northwestern Zone drill hole BL-24-49 intersected 8.65% P2O5 over 33.0 meters from a depth of 72.5 meters while the Southern Zone showed drill hole BL-24-43 intersected 5.41% P2O5 over 258.0 meters from a depth of 111.0 meters. These results demonstrate the significant phosphate potential of the Bégin-Lamarche project, reaffirming the company's commitment to advancing its exploration efforts in the region. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 03, 2024 10:25 AM Eastern Daylight Time

Video
Article thumbnail News Release

Gaming Realms reports record 2023, driven by strong content licensing growth

Gaming Realms PLC

Gaming Realms PLC (AIM:GMR, OTCQX:PSDMF) CEO Mark Segal discusses the company's record-breaking results for 2023 in an interview with Proactive's Stephen Gunnion. The firm witnessed a 26% increase in top-line revenue, reaching £23 million, predominantly fuelled by a 33% growth in its content licensing business, which accounted for £19 million. This expansion was driven by the company's entry into new markets and the introduction of 44 new partners over the year, alongside the launch of innovative games. Gaming Realms' Slingo portfolio led the charge, and it licensed games such as a Tetris-themed game and Space Invaders, leveraging classic video game IPs. Its portfolio of proprietary games expanded to 75, further diversifying its offering. The company also marked its presence in new territories, including West Virginia, Sweden, Greece, and notably Portugal, where it launched in the last quarter of the previous year with positive results. The US emerged as its top market, showing growth of 22%, with the company live in several states and plans to expand into West Virginia. Gaming Realms experienced a significant increase in unique users, exceeding 5 million, with a notable 33% rise in licensing revenue, much of which came from existing partners at the start of 2023. The UK and Canada were highlighted as key markets, with substantial growth observed, particularly in Canada's newly regulated Ontario market and Italy. Looking forward, Segal remains optimistic about 2024, with licensing income already up by 20% in the first two months. The momentum gained since 2019, transitioning from a loss in that year to over £10 million in adjusted EBITDA in 2023, is expected to continue, driven by the compounding effect of new partnerships. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 03, 2024 10:17 AM Eastern Daylight Time

Video
Article thumbnail News Release

ARway.ai sees positive results from deployment of AR wayfinding at campus of Brandenburg University

ARway.ai

ARway.ai Chief Product Officer Shadnam Khan joined Steve Darling from Proactive to unveil the successful deployment of an innovative AR navigation system within the 5G campus network built by Deutsche Telekom AG at the Brandenburg University of Applied Sciences campus in Germany. The fully funded partnership with the Brandenburg University of Applied Sciences and its prestigious institute ifii (Institute for Innovation and Information Management), originally announced in October 2023, revolutionizes the way faculty and visitors experience the university campus. It provides a seamless and intuitive AR experience and AR-powered navigation. As part of their 2024 roadmap, the university will implement, evaluate, and publish research on over 20 different use cases with ARway's technology, highlighting the depth of this collaboration. Khan emphasized that a significant number of master's students are conducting their theses on AR, leveraging the new system for their research. This academic involvement underscores the system's role not only as a navigational tool but also as a platform for academic and technological exploration. The company anticipates that this project will set new standards for digital campus experiences and open new pathways for the application of AR and 5G technologies in various sectors. Contact Details Proactive United States +1 347-449-0879 action@proactiveinvestors.com

April 03, 2024 10:14 AM Eastern Daylight Time

Video
Article thumbnail News Release

HEALWELL AI shares major company milestones since its debut in Q4 of 2023

HEALWELL AI Inc.

HEALWELL AI CEO Dr. Alex Dobranowski joined Steve Darling from Proactive to provide a corporate update, including the release of preliminary financial results for its Fiscal Fourth Quarter and Year Ended December 31, 2023. HEALWELL AI, which debuted in the fourth quarter of 2023, has achieved significant milestones since its inception. HEALWELL successfully raised approximately $29.5 million, providing the company with significant financial resources to fuel its growth initiatives. HEALWELL completed the acquisition of a majority interest in Pentavere, an AI healthcare company. This acquisition enhances HEALWELL's capabilities and strengthens its position in the healthcare AI market. HEALWELL announced a partnership with WELL Health Technologies, whereby WELL Health adopted HEALWELL's AI-powered physician co-pilot product, WELL AI Decision Support. This marks a significant milestone in the adoption of HEALWELL's technology in the healthcare industry. HEALWELL announced the acquisition of Intrahealth, an enterprise-class Electronic Health Record (EHR) company. This acquisition has contributed to HEALWELL's yearly run-rate revenues, which now exceed $20 million, primarily driven by SaaS and services. Dobranowski expressed optimism about HEALWELL's outlook, citing its organic growth profile and M&A strategy. The company has a strong and active acquisition pipeline, with the potential to more than double its current revenue run-rate to over $40 million per year using existing cash on hand. HEALWELL's strategic alliance with equity investor WELL Health Technologies continues to flourish, with significant activity in both Canada and the United States. In Canada, WELL Health recently launched WELL AI Decision Support, an AI-powered physician co-pilot providing clinical decision support for rare disease diagnosis and preventative care, sourced entirely from HEALWELL. Overall, HEALWELL AI is well-positioned for continued growth and success in the dynamic healthcare AI market, leveraging its innovative technology, strategic partnerships, and robust acquisition strategy. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

April 03, 2024 10:07 AM Eastern Daylight Time

Video
Article thumbnail News Release

PathAI Announces Research Presentations at the 2024 AACR Annual Meeting

PathAI

PathAI, Inc., a leading AI-powered precision pathology company, today announced it will present research from its portfolio of oncology products at the AACR Annual Meeting on April 7-10, 2024, in San Diego, CA. The research demonstrates how machine learning models developed to characterize the tumor microenvironment (TME) from routine hematoxylin and eosin (H&E)-stained whole slide images (WSIs) can be used to advance biomarker development and precision medicine strategies. The presentations include new research leveraging PathAI’s pan-tumor foundation models and its commercially available product, PathExplore 1, to identify key histologic features associated with molecular signatures and patient response to therapy. Highlights: Researchers deployed PathExplore on HNSCC and NSCLC samples to characterize the cell and tissue composition of the tumor microenvironment, as well as compute immune phenotypes directly from H&E WSI. (Poster #905 ) Researchers from Incendia Therapeutics developed a continuous scoring method for Discoidin Domain Receptor 1 (DDR1), which revealed widespread immune exclusion in tumors based on the spatial distribution of lymphocytes, CD8+ T cells, and CD45+ immune cells from H&E and mIF images. DDR1 is highly expressed in epithelial cancers and has been implicated in tumor growth, invasion, and lack of response to therapy. The immune exclusion score correlates with DDR1 mRNA and protein expression. The study provides additional insight into the role of DDR1 in human cancers and may be useful in selecting indications and stratifying patients for DDR1-targeted therapies. (Poster #2916 ) Using unsupervised learning driven by PathExplore’s features and a novel collagen fiber detection imaging technology, researchers discovered three distinct phenotypes of cancer associated stroma (CAS) that had distinct patterns of association with survival and gene expression signatures. Two of them were enriched in collagen fiber density as well as in density of fibroblasts, while the third phenotype had the highest density of immune cells, providing a categorization of different types of CAS-tumor interaction that may be useful for patient stratification. (Poster #4912 ) Using AI-powered models from PathAI, Foundation Medicine researchers investigated digital pathology TME features of immunotherapy outcomes among NSCLC patients within a real-world dataset from the Flatiron Health-Foundation Medicine Clinico-Genomic Database. These results indicate that the composition of the TME assessed via digital pathology may have utility in identifying NSCLC patients who will respond to first-line immune checkpoint inhibitors beyond the established immunotherapy biomarkers. (Poster #4969 ) In collaboration with EMD Serono, AI-powered TME models from PathAI were used to analyze H&E WSI of NSCLC from a randomized Phase 3 trial directly comparing two immunotherapies. Researchers compared cell abundance features with gene expression data from the same samples and found that immune and stromal cell abundance features were associated with expression of genes in relevant cellular pathways, confirming the biological relevance of our cellular features. In analyzing the features alongside the clinical data from the retrospective study, researchers identified candidate prognostic immunotherapy biomarkers. (Poster #6179 ) Researchers from Incendia Therapeutics illustrated that morphologic features derived from H&E images using PathExplore can be effective predictors of CD8-defined immune exclusion, providing an option for patient stratification by immune phenotype using widely available H&E images. The features and direction of association align with prior knowledge of the mechanism or manifestations of immune exclusion or infiltration in the TME, including the relative density of lymphocytes in tumor and stroma. (Poster #7392 ) PathAI’s pan-tumor foundation models were used to identify tissue regions and cell types on H&E WSI to quantify tumor purity across multiple tumor types. Model-derived tumor purity estimates were compared to three orthogonal molecular methods of purity and found to correlate across disease indications. These results provide evidence of how AI can improve the efficiency of molecular testing and enhance precision diagnostic strategies. (Poster #7402 ) Follow PathAI on LinkedIn and X for more updates from #AACR24 and visit us in person at booth #1549. 1 PathExplore is For Research Use Only. Not for use in diagnostic procedures. About PathAI PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and laboratory use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of pathology samples to improve efficiency and accuracy of pathology interpretation, as well as to better gauge therapeutic efficacy and accelerate drug development for complex diseases. PathAI, which is headquartered in Boston, MA, and operates a CAP/CLIA-certified laboratory in Memphis, TN, is proud to have a team of 600+ innovative thinkers from around the globe. For more information, please visit www.pathai.com. Contact Details SVM Public Relations and Marketing Communications Maggie Naples +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

April 03, 2024 10:00 AM Eastern Daylight Time

1 ... 327328329330331 ... 3787